APA

Orbe J., Barrenetxe J., Rodriguez J. A., Vivien D., Orset C., Parks W. C., Birkland T. P., Serrano R., Purroy A., Martinez de Lizarrondo S., Angles-Cano E. & Páramo J. A. (20120216). Matrix metalloproteinase-10 effectively reduces infarct size in experimental stroke by enhancing fibrinolysis via a thrombin-activatable fibrinolysis inhibitor-mediated mechanism. : Circulation.

Chicago

Orbe J, Barrenetxe J, Rodriguez J A, Vivien D, Orset C, Parks W C, Birkland T P, Serrano R, Purroy A, Martinez de Lizarrondo S, Angles-Cano E and Páramo J A. 20120216. Matrix metalloproteinase-10 effectively reduces infarct size in experimental stroke by enhancing fibrinolysis via a thrombin-activatable fibrinolysis inhibitor-mediated mechanism. : Circulation.

Harvard

Orbe J., Barrenetxe J., Rodriguez J. A., Vivien D., Orset C., Parks W. C., Birkland T. P., Serrano R., Purroy A., Martinez de Lizarrondo S., Angles-Cano E. and Páramo J. A. (20120216). Matrix metalloproteinase-10 effectively reduces infarct size in experimental stroke by enhancing fibrinolysis via a thrombin-activatable fibrinolysis inhibitor-mediated mechanism. : Circulation.

MLA

Orbe J, Barrenetxe J, Rodriguez J A, Vivien D, Orset C, Parks W C, Birkland T P, Serrano R, Purroy A, Martinez de Lizarrondo S, Angles-Cano E and Páramo J A. Matrix metalloproteinase-10 effectively reduces infarct size in experimental stroke by enhancing fibrinolysis via a thrombin-activatable fibrinolysis inhibitor-mediated mechanism. : Circulation. 20120216.